NOVEL DRUGS IN FOLLICULAR LYMPHOMA
Follicular lymphoma(FL) is the most common indolent non-Hodgkin lymphoma and constitutes 15% to 30% of lymphoma diagnoses. The natural history of the disease is characterized by recurrent relapses and progressively shorter remissions with a median survival of 10yrs. The impossibility of a chieving a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2016-11-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/2707 |